GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medinet Co Ltd (TSE:2370) » Definitions » EV-to-EBIT

Medinet Co (TSE:2370) EV-to-EBIT : -4.26 (As of Dec. 13, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Medinet Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Medinet Co's Enterprise Value is 円5,922.1 Mil. Medinet Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was 円-1,391.8 Mil. Therefore, Medinet Co's EV-to-EBIT for today is -4.26.

The historical rank and industry rank for Medinet Co's EV-to-EBIT or its related term are showing as below:

TSE:2370' s EV-to-EBIT Range Over the Past 10 Years
Min: -22.22   Med: -5.97   Max: -1.53
Current: -4.25

During the past 13 years, the highest EV-to-EBIT of Medinet Co was -1.53. The lowest was -22.22. And the median was -5.97.

TSE:2370's EV-to-EBIT is ranked worse than
100% of 420 companies
in the Biotechnology industry
Industry Median: 10.01 vs TSE:2370: -4.25

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Medinet Co's Enterprise Value for the quarter that ended in Mar. 2024 was 円8,164.4 Mil. Medinet Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was 円-1,391.8 Mil. Medinet Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -17.05%.


Medinet Co EV-to-EBIT Historical Data

The historical data trend for Medinet Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medinet Co EV-to-EBIT Chart

Medinet Co Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.63 -12.78 -10.06 -13.02 -5.03

Medinet Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.23 -8.01 -5.03 -4.19 -5.87

Competitive Comparison of Medinet Co's EV-to-EBIT

For the Biotechnology subindustry, Medinet Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medinet Co's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medinet Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Medinet Co's EV-to-EBIT falls into.



Medinet Co EV-to-EBIT Calculation

Medinet Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=5922.068/-1391.786
=-4.26

Medinet Co's current Enterprise Value is 円5,922.1 Mil.
Medinet Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-1,391.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medinet Co  (TSE:2370) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Medinet Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=-1391.786/8164.403
=-17.05 %

Medinet Co's Enterprise Value for the quarter that ended in Mar. 2024 was 円8,164.4 Mil.
Medinet Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-1,391.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medinet Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Medinet Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Medinet Co Business Description

Traded in Other Exchanges
N/A
Address
2-3-12 Shin-Yokohama, Shin-Yokohama Square Building, 14 Floor, Kohoku-ku, Yokohama, JPN, 222-0033
Medinet Co Ltd is a Japan-based Contract Development and Manufacturing Organization (CDMO). The company is engaged in the research and development of regenerative medical products, investigational products, and specified cell products. MEDINET is a one-stop regenerative medicine and cell therapy solution provider. It provides value chain solutions including personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management solutions to medical institutions, research institutions, and biopharmaceutical companies.

Medinet Co Headlines

No Headlines